EDITSCD & ERN-EuroBloodNet: Focus on Genetic Therapy for People Living with SCD

ERN-EuroBloodNet and the EDITSCD Consortium are launching a series of webinars aimed at providing an overview of gene therapy and genome editing approaches for Sickle Cell Disease (SCD). 

The sessions will be led by renowned experts in the field and are designed to offer both fundamental knowledge and advanced perspectives, from disease mechanisms to clinical translation, to audience. Topics will cover lentiviral gene therapy, CRISPR/Cas9 tools and safety, as well as regulatory aspects and clinical trials.